PARTELLI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 7.777
AS - Asia 6.690
NA - Nord America 5.185
SA - Sud America 1.513
AF - Africa 142
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.329
Nazione #
US - Stati Uniti d'America 4.936
RU - Federazione Russa 4.582
SG - Singapore 2.436
CN - Cina 2.059
BR - Brasile 1.241
HK - Hong Kong 888
SE - Svezia 790
IT - Italia 656
VN - Vietnam 649
DE - Germania 351
FR - Francia 331
RO - Romania 266
GB - Regno Unito 240
IN - India 185
FI - Finlandia 168
CA - Canada 129
AR - Argentina 116
MX - Messico 83
BD - Bangladesh 73
PL - Polonia 69
ES - Italia 66
JP - Giappone 63
AT - Austria 59
ZA - Sudafrica 56
IE - Irlanda 54
NL - Olanda 52
ID - Indonesia 51
TR - Turchia 46
EC - Ecuador 41
IQ - Iraq 38
CO - Colombia 33
PK - Pakistan 29
PH - Filippine 22
LT - Lituania 21
PY - Paraguay 21
NP - Nepal 19
UA - Ucraina 19
UZ - Uzbekistan 19
VE - Venezuela 18
CL - Cile 17
MA - Marocco 17
AU - Australia 14
DZ - Algeria 14
EG - Egitto 14
KE - Kenya 12
SA - Arabia Saudita 12
TN - Tunisia 12
PE - Perù 11
BE - Belgio 10
AE - Emirati Arabi Uniti 9
IL - Israele 9
IR - Iran 9
JO - Giordania 9
KZ - Kazakistan 9
BH - Bahrain 8
CH - Svizzera 8
UY - Uruguay 8
MY - Malesia 7
RS - Serbia 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
GR - Grecia 5
HN - Honduras 5
JM - Giamaica 5
PS - Palestinian Territory 5
PT - Portogallo 5
TH - Thailandia 5
TW - Taiwan 5
CR - Costa Rica 4
OM - Oman 4
PA - Panama 4
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GE - Georgia 3
KR - Corea 3
LB - Libano 3
MD - Moldavia 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
AL - Albania 2
BN - Brunei Darussalam 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EU - Europa 2
KG - Kirghizistan 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SV - El Salvador 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
Totale 21.312
Città #
Singapore 1.200
Moscow 955
Dallas 918
Hong Kong 875
Ashburn 848
San Jose 546
Shanghai 388
Beijing 313
Hefei 305
Lauterbourg 252
New York 251
Ho Chi Minh City 219
Milan 219
Lawrence 197
Princeton 194
Los Angeles 187
Hanoi 136
São Paulo 136
Boardman 107
Munich 100
Helsinki 89
London 84
Orem 84
Nuremberg 78
Santa Clara 69
Chennai 59
Dublin 54
Montreal 53
Tokyo 52
Warsaw 52
Rio de Janeiro 51
Turku 49
Denver 45
Frankfurt am Main 45
Poplar 44
Rome 44
Atlanta 41
The Dalles 41
Brooklyn 40
Manchester 36
Chicago 35
Johannesburg 35
Stockholm 35
Council Bluffs 34
Guangzhou 34
Washington 31
Phoenix 30
Boston 29
Mexico City 29
Columbus 28
Belo Horizonte 27
Lappeenranta 27
Pune 27
Toronto 27
Vienna 27
Haiphong 26
Da Nang 25
Brasília 23
Mumbai 23
San Francisco 23
Seattle 21
Ankara 20
Cesano Boscone 20
Shenzhen 20
Biên Hòa 19
Amsterdam 18
Houston 18
Dhaka 17
Tashkent 17
Campinas 16
Falkenstein 16
Thái Bình 16
Tianjin 16
New Delhi 14
Baghdad 13
Cape Town 13
Hải Dương 13
Porto Alegre 13
Ribeirão Preto 13
Asunción 12
Barnet 12
Bắc Ninh 12
Quito 12
Dalian 11
Guayaquil 11
Madrid 11
Ottawa 11
Paris 11
Querétaro 11
Romagnano Sesia 11
Assago 10
Guarulhos 10
Joinville 10
Naples 10
Salvador 10
Sydney 10
Valencia 10
Brussels 9
Bắc Giang 9
Campo Grande 9
Totale 10.566
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 353
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 173
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 172
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 164
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 160
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 156
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 156
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 154
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 140
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 138
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 131
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 130
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 125
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 123
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 121
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 121
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 116
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 114
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 114
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 113
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 113
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 113
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 112
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 112
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 112
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 111
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 111
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 109
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 108
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 108
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 108
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 108
The impact of preoperative anemia on pancreatic resection outcomes 106
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 105
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 105
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 103
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 103
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 102
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 102
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 102
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 102
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 102
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 100
Impact of care pathway adherence on recovery following distal pancreatectomy within an enhanced recovery program 100
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 100
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 99
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 99
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 99
A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors 99
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 98
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 98
ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing 98
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients 98
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 96
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 96
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 96
Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy 96
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 96
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 95
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 95
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 95
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer 95
Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system 95
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 94
A systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein 94
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 93
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 93
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 93
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 93
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 92
Validation of the PROMIS-29 Questionnaire as a Measure of Recovery After Pancreatic Surgery 91
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 91
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 91
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy 90
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 90
Non functional pancreatic neuroendocrine tumors 90
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 90
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 90
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 89
The impact of minimally invasive surgery on hospital readmissions, emergency department visits and functional recovery after distal pancreatectomy 89
Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge 88
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 88
Single snapshot imaging of optical properties (SSOP) for perfusion assessment during gastric conduit creation for esophagectomy: An experimental study on pigs 88
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 87
New Surgical Strategies 87
ASO Author Reflections: Can We Evaluate Surgical Quality for Pancreatic Neuroendocrine Tumors? 87
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 86
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 85
Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 85
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms 85
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer 85
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 84
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 84
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 84
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 84
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 84
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 83
Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy 83
Correction to: Italian survey about intraperitoneal drain use in distal pancreatectomy (Updates in Surgery, (2024), 10.1007/s13304-024-01987-0) 83
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 81
Totale 10.628
Categoria #
all - tutte 117.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.941


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 2 7 53 5 5 7 4 10 9 4 13
2022/20231.396 449 281 91 29 23 193 96 106 76 17 14 21
2023/20241.177 24 68 126 128 116 242 27 115 19 34 77 201
2024/20254.666 488 118 128 148 166 406 944 382 692 482 303 409
2025/202614.288 1.008 1.082 1.080 2.120 1.175 550 1.305 1.154 4.153 661 0 0
Totale 21.747